Skip navigation

Calls to Action

Mustafa Sahin

May 14, 2016

Mustafa Sahin discusses how fine-tuning clinical trials of tuberous sclerosis drugs can advance broader development of autism medicines

October 15, 2015

Today in Science magazine: What’s next in the development of individualized treatments for autism?

October 02, 2013

Veteran autism researchers partner in an effort to facilitate the discovery of effective treatments for individuals with autism

September 02, 2013

Sunday's Boston Globe reports on a study of the drug rapamycin in children with tuberous sclerosis complex

July 12, 2012

Deleting one gene in certain brain cells causes autism behaviors in mice; rapamycin prevents same symptoms.